164 related articles for article (PubMed ID: 37308975)
1. Increasing angiotensin-converting enzyme concentrations and absent angiotensin-converting enzyme activity are associated with adverse kidney outcomes in pediatric septic shock.
Pode-Shakked N; Ceschia G; Rose JE; Goldstein SL; Stanski NL;
Crit Care; 2023 Jun; 27(1):230. PubMed ID: 37308975
[TBL] [Abstract][Full Text] [Related]
2. Serum renin and prorenin concentrations predict severe persistent acute kidney injury and mortality in pediatric septic shock.
Stanski NL; Pode Shakked N; Zhang B; Cvijanovich NZ; Fitzgerald JC; Jain PN; Schwarz AJ; Nowak J; Weiss SL; Allen GL; Thomas NJ; Haileselassie B; Goldstein SL
Pediatr Nephrol; 2023 Sep; 38(9):3099-3108. PubMed ID: 36939916
[TBL] [Abstract][Full Text] [Related]
3. Neurohormonal reactivation in heart failure patients on chronic ACE inhibitor therapy: a longitudinal study.
Lee AF; MacFadyen RJ; Struthers AD
Eur J Heart Fail; 1999 Dec; 1(4):401-6. PubMed ID: 10937954
[TBL] [Abstract][Full Text] [Related]
4. Treatment of Renin-Angiotensin-Aldosterone System Dysfunction With Angiotensin II in High-Renin Septic Shock.
Chow JH; Wallis M; Lankford AS; Chancer Z; Barth RN; Scalea JR; LaMattina JC; Mazzeffi MA; McCurdy MT
Semin Cardiothorac Vasc Anesth; 2021 Mar; 25(1):67-73. PubMed ID: 32787515
[TBL] [Abstract][Full Text] [Related]
5. Renin-Angiotensin System Blockade after Acute Kidney Injury (AKI) and Risk of Recurrent AKI.
Hsu CY; Liu KD; Yang J; Glidden DV; Tan TC; Pravoverov L; Zheng S; Go AS
Clin J Am Soc Nephrol; 2020 Jan; 15(1):26-34. PubMed ID: 31843974
[TBL] [Abstract][Full Text] [Related]
6. Association between exposure to angiotensin-converting enzyme inhibitors and angiotensin receptor blockers prior to septic shock and acute kidney injury.
Suberviola B; Rodrigo E; González-Castro A; Serrano M; Heras M; Castellanos-Ortega Á
Med Intensiva; 2017; 41(1):21-27. PubMed ID: 28341094
[TBL] [Abstract][Full Text] [Related]
7. Plasma and tissue angiotensin-converting enzyme 2 activity and plasma equilibrium concentrations of angiotensin peptides in dogs with heart disease.
Larouche-Lebel É; Loughran KA; Oyama MA; Solter PF; Laughlin DS; Sánchez MD; Assenmacher CA; Fox PR; Fries RC
J Vet Intern Med; 2019 Jul; 33(4):1571-1584. PubMed ID: 31254308
[TBL] [Abstract][Full Text] [Related]
8. Angiotensinogen (M235T) and angiotensin-converting enzyme (I/D) polymorphisms in association with plasma renin and prorenin levels.
Danser AH; Derkx FH; Hense HW; Jeunemaître X; Riegger GA; Schunkert H
J Hypertens; 1998 Dec; 16(12 Pt 2):1879-83. PubMed ID: 9886872
[TBL] [Abstract][Full Text] [Related]
9. The role of renin-angiotensin system in sepsis-associated acute kidney injury: mechanisms and therapeutic implications.
Garcia B; Zarbock A; Bellomo R; Legrand M
Curr Opin Crit Care; 2023 Dec; 29(6):607-613. PubMed ID: 37861190
[TBL] [Abstract][Full Text] [Related]
10. The effect of renin-angiotensin-aldosterone system blockade on contrast-induced acute kidney injury: a propensity-matched study.
Rim MY; Ro H; Kang WC; Kim AJ; Park H; Chang JH; Lee HH; Chung W; Jung JY
Am J Kidney Dis; 2012 Oct; 60(4):576-82. PubMed ID: 22658321
[TBL] [Abstract][Full Text] [Related]
11. Association of Active Renin Content With Mortality in Critically Ill Patients: A Post hoc Analysis of the Vitamin C, Thiamine, and Steroids in Sepsis (VICTAS) Trial.
Busse LW; Schaich CL; Chappell MC; McCurdy MT; Staples EM; Ten Lohuis CC; Hinson JS; Sevransky JE; Rothman RE; Wright DW; Martin GS; Khanna AK;
Crit Care Med; 2024 Mar; 52(3):441-451. PubMed ID: 37947484
[TBL] [Abstract][Full Text] [Related]
12. Angiotensin-converting enzyme gene polymorphism has no influence on the circulating renin-angiotensin-aldosterone system or blood pressure in normotensive subjects.
Lachurié ML; Azizi M; Guyene TT; Alhenc-Gelas F; Ménard J
Circulation; 1995 Jun; 91(12):2933-42. PubMed ID: 7796503
[TBL] [Abstract][Full Text] [Related]
13. The renin-angiotensin-aldosterone system, neurohumoral axis and cardiovascular mortality in LURIC.
Yazdani B; Delgado GE; Kleber ME; Yücel G; Husain-Syed F; Kraemer TD; Jochims J; Leipe J; März W; Krämer BK
J Clin Hypertens (Greenwich); 2022 Dec; 24(12):1587-1597. PubMed ID: 36349861
[TBL] [Abstract][Full Text] [Related]
14. IMPACT OF THE ANGIOTENSIN-CONVERTING ENZYME (ACE) INHIBITORS ON THE COURSE OF THE SEPTIC SHOCK DEVELOPED DURING COVID-19 AND OTHER SEVERE RESPIRATORY INFECTIONS IN PRESENCE OF HYPERFERRITINEMIA.
Rurua M; Ratiani L; Sanikidze T; Machvariani K; Pachkoria E; Ormocadze G; Mikadze I; Didbaridze T
Georgian Med News; 2023 Apr; (337):110-117. PubMed ID: 37354683
[TBL] [Abstract][Full Text] [Related]
15. Kidney Function and Potassium Monitoring After Initiation of Renin-Angiotensin-Aldosterone System Blockade Therapy and Outcomes in 2 North American Populations.
Parikh RV; Nash DM; Brimble KS; Markle-Reid M; Tan TC; McArthur E; Khoshniat-Rad F; Sood MM; Zheng S; Pravoverov L; Nesrallah GE; Garg AX; Go AS
Circ Cardiovasc Qual Outcomes; 2020 Sep; 13(9):e006415. PubMed ID: 32873054
[TBL] [Abstract][Full Text] [Related]
16. Urinary renin, but not angiotensinogen or aldosterone, reflects the renal renin-angiotensin-aldosterone system activity and the efficacy of renin-angiotensin-aldosterone system blockade in the kidney.
van den Heuvel M; Batenburg WW; Jainandunsing S; Garrelds IM; van Gool JM; Feelders RA; van den Meiracker AH; Danser AH
J Hypertens; 2011 Nov; 29(11):2147-55. PubMed ID: 21941204
[TBL] [Abstract][Full Text] [Related]
17. Renin-angiotensin aldosterone profile before and after angiotensin-converting enzyme-inhibitor administration in dogs with angiotensin-converting enzyme gene polymorphism.
Adin D; Atkins C; Domenig O; DeFrancesco T; Keene B; Tou S; Stern JA; Meurs KM
J Vet Intern Med; 2020 Mar; 34(2):600-606. PubMed ID: 32112596
[TBL] [Abstract][Full Text] [Related]
18. Acute kidney injury in patients with sepsis and septic shock: risk factors and clinical outcomes.
Suh SH; Kim CS; Choi JS; Bae EH; Ma SK; Kim SW
Yonsei Med J; 2013 Jul; 54(4):965-72. PubMed ID: 23709433
[TBL] [Abstract][Full Text] [Related]
19. Prospective Cohort Study of Renin-Angiotensin System Blocker Usage after Hospitalized Acute Kidney Injury.
Brar S; Liu KD; Go AS; Hsu RK; Chinchilli VM; Coca SG; Garg AX; Himmelfarb J; Ikizler TA; Kaufman J; Kimmel PL; Parikh CR; Siew ED; Ware LB; Zeng H; Hsu CY; ;
Clin J Am Soc Nephrol; 2020 Dec; 16(1):26-36. PubMed ID: 33272913
[TBL] [Abstract][Full Text] [Related]
20. Renin-angiotensin aldosterone inhibitor use at hospital discharge among patients with moderate to severe acute kidney injury and its association with recurrent acute kidney injury and mortality.
Siew ED; Parr SK; Abdel-Kader K; Perkins AM; Greevy RA; Vincz AJ; Denton J; Wilson OD; Hung AM; Ikizler TA; Robinson-Cohen C; Matheny ME
Kidney Int; 2021 May; 99(5):1202-1212. PubMed ID: 32916177
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
